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Abstract 
Obstructive sleep apnea (OSA) is a common heritable disorder displaying marked sexual 
dimorphism in disease prevalence and progression. Previous genetic association studies have 
identified a few genetic loci associated with OSA and related quantitative traits, but they have 
only focused on single ethnic groups and a large proportion of the heritability remains 
unexplained. The apnea hypopnea index (AHI) is a commonly used quantitative measure 
characterizing OSA severity. Since OSA differs by sex, and the pathophysiology of obstructive 
events differ in rapid eye movement (REM) and non-REM (NREM) sleep, we hypothesized that 
additional genetic association signals would be identified by analyzing the NREM/REM-specific 
AHI and by conducting sex-specific analyses in multi-ethnic samples. We performed genome-
wide association tests for up to 19,733 participants of African-, Asian-, European-, and 
Hispanic/Latino-American ancestry in seven studies. We identified rs12936587 on chromosome 
17 as a possible quantitative trait locus for NREM AHI in men (N = 6,737; P = 1.7 × 10-8), but 
not in women (P = 0.77). The association with NREM AHI was replicated in a physiological 
research study (N = 67; P = 0.047). This locus overlapping the RAI1 gene and encompassing 
genes PEMT1, SREBF1 and RASD1, was previously reported to be associated with coronary 
artery disease, lipid metabolism, and implicated in Potocki-Lupski Syndrome and Smith-
Magenis Syndrome, which are characterized by abnormal sleep phenotypes. We also identified 
gene-by-sex interactions in suggestive association regions, suggesting that genetic variants for 
AHI appear to vary by sex, consistent with the clinical observations of strong sexual dimorphism. 
 
Keywords: obstructive sleep apnea, genetics, genome-wide association studies, multi-ethnic, 
sexual dimorphism.
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Introduction 
Obstructive Sleep Apnea (OSA) is a complex chronic condition that affects more than 10% of the 
population, and is associated with cardio-metabolic and behavioral morbidity (1-3). The 
prevalence of OSA is particularly high in minority racial/ethnic groups such as those with 
African-, Asian- and Hispanic ancestry (4-7). Moreover, OSA is approximately 3-fold more 
prevalent in men as compared to women (8). In women, OSA severity is less likely to worsen in 
the supine compared to other sleeping positions (9) and more likely to worsen in rapid eye 
movement (REM) sleep, when neuromuscular tone and chemoreflexes are reduced (9, 10). These 
differences have been attributable to sex differences in airway-collapsibility, related to both 
differences in anatomy and respiratory chemosensitivity (11). An increase in OSA severity in 
women after menopause also suggests a role for sex hormones in influencing this disorder (12). 
 
The severity of OSA is most often characterized by the apnea hypopnea index (AHI), defined as 
the number of apnea and hypopnea events per hour of sleep. AHI levels are highly heritable in 
African-Americans and European-Americans, with 30 to 40% of the variance explained by 
genetic factors (13, 14). Previous genetic studies have identified several genetic variants 
associated with AHI, although these findings were based on modest sample sizes or single ethnic 
groups, and largely have not been replicated across populations (15-18).   
 
Large-scale genome-wide association studies (GWAS) have identified sexual dimorphism in 
genetic loci for traits associated with OSA, such as body fat distribution, particularly waist 
circumference and waist-to-hip ratio, each adjusted for body mass index (BMI) (19, 20). 
Furthermore, measures of adiposity such as waist phenotypes have been shown to be regulated 
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by sexually dimorphic genes (19, 21). Animal models suggest that both gonadal hormones and X 
chromosome dose influence lipid levels (22). Despite strong clinical and epidemiological 
evidence for sex differences in OSA, prior genetic association studies were not sufficiently 
powered to study consistent sex differences in OSA in multi-ethnic samples (15-17).  
 
We conducted genome-wide association studies in multi-ethnic samples from 7 cohorts to 
identify genetic variants with sex-specific association for AHI. Given differences in the 
physiological bases for OSA in REM and non-REM sleep (23), we performed analyses for AHI 
calculated for each sleep state (REM; non-REM). Although BMI is a significant risk factor for 
OSA, only 40% of the genetic variance for OSA is shared with BMI (14).Therefore, we adjusted 
for BMI in order to discover genetic loci acting independently of BMI, which may provide 
insights into novel etiological mechanisms. We focused on association signals that show 
concordant direction of effects across African-, Asian-, Hispanic/Latino- and European-
Americans through BMI-independent pathways. 
 
Materials and Methods 
Study Subjects 
We included seven cohorts in the discovery analyses: the Atherosclerosis Risk in Communities 
Study (ARIC, n=1,463 European-Americans), the Cleveland Family Study (CFS, n=731 African-
Americans and 702 European-Americans), the Framingham Heart Study (FHS, n=646 European-
Americans), the Hispanic Community Health Study / Study of Latinos (HCHS/SOL, n=11,317 
Hispanic/Latino-Americans), the Multi-Ethnic Study of Atherosclerosis (MESA, n=490 African-
Americans, 228 Asian-Americans, 707 European-Americans, and 458 Hispanic/Latino-
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Americans), the Osteoporotic Fractures in Men Study (MrOS, n=2,209 European-Americans), 
and the Starr County Health Studies (Starr, n=782 Hispanic/Latino-Americans) (Table 1). An 
additional six cohort studies and data from one physiological research study were analyzed to 
examine for generalizability across samples. Details about the study subjects are provided in the 
online supplement. 
 
Phenotypes and Covariates 
OSA was quantified using the AHI, defined as the number of episodes of complete (apnea) or 
partial (hypopnea) cessations of airflow per hour of sleep (or recording time). In this study, sleep 
data from all seven discovery studies were scored in our Sleep Reading Center. Details of the 
sleep testing and scoring procedures for each cohort are provided in the online supplement. The 
primary phenotype was the AHI calculated across the total sleep (or recording) period (AHI-
Total; AHI-T). All studies used a hypopnea definition that required a > 3% event-related 
desaturation. Covariates include age, sex and BMI. AHI measured during REM (AHI-R) and 
non-REM (AHI-N) sleep periods also were analyzed where available (ARIC, CFS, FHS, MESA 
and MrOS).  
 
Genotyping and Quality Control 
Study participants in ARIC, MESA, and Starr County were genotyped using the Affymetrix 6.0 
array; CFS participants were genotyped using the Illumina OmniExpress, Affymetrix 6.0 and the 
ITMAT-Broad-CARe (IBC) (24) arrays; FHS participants were genotyped using the Affymetrix 
500K mapping array and Illumina Omni5 array; HCHS/SOL participants were genotyped using 
the Illumina Omni 2.5M array with custom content; and MrOS participants were genotyped 
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using the Illumina Omni 1M array. Data from CFS, FHS, MESA, MrOS and Starr were phased 
using SHAPEIT (25) and imputed using IMPUTE2 (26) and a 1000 Genomes Project Phase 3 
background (version 5, all populations, which contains haplotypes on 2,504 samples for a total of 
about 81.2 million polymorphic markers); ARIC and HCHS/SOL were imputed using a 1000 
Genomes Project Phase 1 background. Single nucleotide polymorphism (SNP) strands were 
checked in Ensembl and with 1000 Genomes data in SHAPEIT. SNPs with an IMPUTE2 Info 
score less than 0.88, or a minor allele frequency less than 1% in each study cohort were excluded 
from analyses.  
 
Statistical Analysis 
Rank normalized age and sex-adjusted residuals were analyzed using linear mixed models with a 
genetic relatedness matrix (GRM) in GEMMA (27) to control for population stratification and 
relatedness, adjusting for BMI and BMI2. Multi-ethnic meta-analyses were performed using the 
inverse variance weighted fixed-effects approach in METAL (28). Details on statistical analysis 
are provided in the online supplement. 
 
Results 
Demographics 
Key characteristics of each cohort were presented in Table 1, with additional details in the online 
supplement. Across the seven distinct cohorts, data were available for 19,733 individuals, 
including 10,113 women. Participants were on average middle-aged to elderly and are 
overweight to obese. The proportion with moderate to severe sleep apnea (AHI ≥ 15 events per 
hour) ranged from 11.7% to 54.8%. In general, the AHI varied with the mean age of the cohort 
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(higher in the older cohorts). Overall, the sample ancestry was 29.0% European, 6.2% African, 
63.6% Hispanic and 1.2% Asian. 
 
Sex-Combined and Sex-Stratified Analyses 
The top results of the multi-ethnic meta-analyses were shown in Table 2. In sex-combined results, 
eight loci showed suggestive association (P < 1.0 × 10-6) with AHI-T, five loci with AHI-N, and 
two loci with AHI-R. These regions included rs146579140, where variation was associated with 
AHI-N at an almost significant level (P = 8.8 × 10-8). In sex-stratified results, six loci showed 
suggestive association with AHI-T, three loci with AHI-N, and three loci with AHI-R in women; 
eleven loci showed suggestive association with AHI-T, three loci with AHI-N, and two loci with 
AHI-R in men. In addition, there was one locus significantly associated with AHI-N in men on 
chromosome 17 (Figure 1), with a lead SNP rs12936587 (P = 1.7 × 10-8). This locus overlapped 
with the gene RAI1 (Figure 1C), which codes retinoic acid induced 1 that has been implicated in 
Smith-Magenis Syndrome (SMS)(29). This lead SNP also showed suggestive association with 
AHI-N in sex-combined analysis, although the findings reflected associations in men and not 
women. Figure 2 showed that compared to men with a homozygous genotype of the ancestral 
allele (A), men with more risk alleles (G) had a higher age- and BMI-adjusted AHI-N on average, 
but there was no such pattern in women.  
 
Gene-by-Sex Interaction 
We performed gene-by-sex interaction analyses for top loci in Table 2 and identified thirteen 
gene-sex interactions in multi-ethnic meta-analyses, after Bonferroni correction to control for 
family-wise significance level of 0.05. Of these thirteen gene-sex interactions, twelve had 
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significant or suggestive association in men but not in women (including rs12936587 with AHI-
N; interaction P = 2.6 × 10-5), and one had suggestive association in sex-combined results but 
neither in men nor in women (although the P value in men was still several orders of magnitude 
lower than in women). These results suggested there might be different genetic mechanisms for 
obstructive sleep apnea in women and men. 
 
Expression Quantitative Trait Loci Databases 
We examined our most significant SNPs in the RAI1 region (NCBI build 37 locations: 
chr17:17531709-17644364; P < 1 × 10-7) in expression quantitative trait loci (eQTLs) databases 
that associate SNPs with gene expression in specific cell lines and tissues (Table E1). Five of the 
eight genes associated with the RAI1 locus SNPs had minimum eQTL P < 1 × 10-6: PEMT 
(whole blood P = 2.1 × 10-20), SREBF1 (whole blood P = 5.0 × 10-20), RASD1 (monocyte P = 6.8 
× 10-12), RAI1 (lymphoblastoid P = 3.4 × 10-7), and TOM1L2 (pituitary P = 9.4 × 10-7). 
 
Assessment of Generalizability in Independent Samples 
In summary data provided by replication cohort studies (Table E2), we found no evidence for 
association with AHI-N for RAI1 in men (P = 0.34). However, a consistent direction of 
association was found in the Cardiovascular Health Study (CHS), the only replication cohort in 
which sleep studies were scored by the same Sleep Reading Center that scored data in the 
discovery cohorts. 
 
We replicated the association with rs12936587 in an independent physiological research study of 
67 individuals (70% male) (Table E3) studied with in-laboratory polysomnography for the 
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purposes of elucidating the physiology of OSA. Details about the study subjects are provided in 
the online supplement. The sample included 55 patients with moderate to severe OSA without 
other significant co-morbidities and 12 healthy controls. In this well phenotyped sample, after 
adjusting for age, sex and BMI, the risk G allele of rs12936587 was associated with increasing 
AHI-N (P = 0.047). The association was stronger when we restricted the analysis to AHI-N in 
the supine position (P = 0.017), when airway collapsibility is high. 
 
Discussion 
To our knowledge, this is the largest genome-wide analysis of AHI and the only multi-ethnic sex-
specific AHI meta-analysis to date. It is also the first human genetic epidemiological study that 
has examined AHI in REM- and non-REM sleep. Analyses of rigorously collected quantitative 
sleep data and genome-wide genotype data identified several novel genetic regions with at least 
suggestive association evidence with each AHI measure. The most significant findings emerged 
from sex-specific and sleep state-specific analyses. Across all cohorts and race/ethnic groups, the 
most significant finding was for an association between a locus in RAI1 in men for AHI 
measured in Non-REM sleep. Our results identify several biologically-plausible candidates for 
future functional studies, and highlight genetic variants that may specifically influence OSA 
propensity in REM vs non-REM sleep, which may have different associations in men and 
women. The finding of multiple significant gene-by-sex interactions further provides statistical 
evidence of distinct genetic mechanisms influencing OSA in men and women. 
 
RAI1 is a promising candidate gene for OSA. It encodes a protein that is highly expressed in 
neuronal tissues and is involved in early neural differentiation and transcriptional regulation of 
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circadian clock components. Haploinsufficiency of the RAI1 gene has been implicated in Smith 
Magenis Syndrome (SMS) (29), a complex neurobehavioral disorder that is characterized by 
multiple craniofacial abnormalities, sleep disturbances, and obesity (30). The craniofacial 
features include a brachycephalic head form and mid face hypoplasia, which are anatomic risk 
factors for OSA (30, 31). A majority of individuals with SMS have significant sleep difficulties 
and disturbed sleep architecture and circadian rhythms (32) and excessive daytime sleepiness. 
Speech abnormalities, a hoarse voice, and airway hypotonia are also reported (33), suggesting a 
role of RAI1 in influencing upper airway function. Abnormalities in RAI1 also have been 
implicated in Potocki-Lupski Syndrome (PTLS) (34-36). PTLS patients often have 
developmental delay and mild dysmorphic facial features (34, 35), and can exhibit multiple 
neurological and cardiovascular abnormalities. Eight of the nine patients with PTLS in the initial 
study displayed central and/or obstructive sleep apnea (36). Both SMS and PTLS appear to 
involve the RAI1 gene on the short arm of chromosome 17 (37). A de novo RAI1 mutation has 
been reported in a boy with rapid-onset obesity with hypothalamic dysfunction, hypoventilation, 
and autonomic dysregulation. The individual displayed an AHI of 10 at age 5 and 27 at age 8, 
hypercholesterolemia, and macrocephaly (38). In mice, Rai1 haploinsufficiency is associated 
with hyperphagia and obesity and abnormal expression of multiple genes in the hypothalamus, 
including BNDF (associated with behavioral and psychiatric morbidities) and WNT9B 
(associated with midfacial development) (39). Although the authors suggested the value in 
further investigating the role of RAI1 in growth, adiposity and behavior, our results also suggest 
value in considering sleep apnea as a relevant RAI1 phenotype.  
 
RAI1 and other genes in the locus may be involved in OSA etiology. Multiple SNPs in the locus 
overlap epigenetic and/or expression quantitative trait loci (eQTL) evidence that may indicate 
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regulatory effects. The SNP rs12938840 (P = 3.97 x 10-7) overlaps enhancer regions in 127 
Roadmap Epigenomics and ENCODE cell lines and in a further 129 samples of brain regions 
(40-43). Lead SNPs are associated with expression of five genes (minimum eQTL P < 1 × 10-6; 
Table E1), including PEMT, SREBF1, RAI1, and RASD1 (44-47). SREBF1 (formerly SREBP1), 
an important cholesterol biosynthesis regulator, is activated in mice subjected to intermittent 
hypoxia, leading to hyperlipidemia (48). Activation of Srebf1 in mouse type 2 alveolar cells leads 
to lipotoxicity, chronic pulmonary inflammation, and alveolar remodeling (49). Pemt, also 
involved with lipid metabolism, displays sex-specific effects in regulation of HDL and VLDL in 
mice (50). A waist-hip ratio GWAS association with rs4646404 at the PEMT locus was largely 
sex-specific (21). RAI1 and RASD1 (formerly DEXRAS1) regulate circadian rhythm (32, 51, 52). 
Rai1 haploinsufficiency in mice leads to sex-specific differences in subcutaneous and abdominal 
fat distributions (39). The lead SNP rs12936587 (RAI1) is also significantly associated with 
coronary artery disease. A sex-stratified analysis indicated that this result was almost entirely due 
to an association in men (53), providing an exciting avenue for investigating sex differences in 
not only OSA but also in the association between OSA with coronary artery disease (reported to 
be stronger in men compared to women) (2). These results also support the importance of future 
assessment of pleiotropy, specifically the influence of genetic variants that influence both OSA 
and cardio-metabolic disease and other co-occurring traits. 
 
There are several possible explanations for stronger associations between the RAI1 locus and 
AHI-N in men compared to women. Men are more likely to have a higher AHI in non-REM 
sleep than women (9), which has been attributed to poorer neuromuscular compensatory 
mechanisms. Thus, genetic variants that further reduce airway patency or ventilatory stability in 
11 
 
sleep may have stronger effects in men due to underlying anatomic or physiological risk factors. 
Conversely, factors that protect women in NREM sleep from recurrent apneas, such as sex 
hormone-mediated modulation of respiratory chemosensitivity in NREM sleep, may attenuate 
effects of some genetic variants. It is also possible that sex steroids interact with genetic variants 
in RAI1 to differentially affect the development of the brain or craniofacial structures, or 
otherwise interact with genes regulated by sex hormones. RAI1 is upregulated by retinoic acid, 
which can interact with sex steroids. In the western mosquitofish, Gambusia affinis, retinoic acid 
controls sex-specific development of motor neurons within the spinal cord (54). Furthermore, it 
has been reported that male Rai1-transgenic mice are more growth retarded than are female 
transgenic mice (55). Rai1 haploinsufficiency in mice leads to sex-specific differences in 
adiposity, with greater abdominal fat in females compared to males (39). 
 
This study has several strengths, including the rigorous phenotyping for all discovery cohorts by 
a central Sleep Reading Center of the sleep studies to ensure high degrees of quality control. 
Participants in 5 of the 7 cohorts were studied using almost identical equipment and scoring 
techniques. Consistency of findings for our most significant finding was observed across the 5 
distinct discovery cohorts with available data on NREM AHI as well as across all ethnic/racial 
groups, even when using data from alternative sleep apnea testing devices. The inclusion of 
multiple ethnic/race groups allowed leveraging different LD structures across populations to 
identify genetic variants consistently associated with the phenotypes across multiple ethnic/race 
groups. Genome-wide genotype data were available for the largest sample with OSA phenotypes 
to date. 
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The AHI was defined using standard approaches that are used commonly, are reproducible, and 
show heritability. Hypopneas minimally required a ≥ 3% oxyhemoglobin desaturation. Although 
AHI levels are highly correlated regardless of hypopnea definition (56), it is possible that 
associations may have varied because of use of different measurement approaches. The strongest 
findings for the NREM AHI may not only reflect the specificity of this phenotype, but also the 
greater accuracy of AHI measures scored from polysomnograms that include 
electroencephalography recording. The power for replication was limited due to modest sample 
size (particularly for stage-specific results), although associations in the CHS European-
Americans, which had undergone identical phenotyping as several of the discovery cohorts, 
provided evidence consistent with the discovery finding in the RAI1 region. In addition, in an 
independent in-laboratory physiological research study of carefully phenotyped individuals that 
explicitly recruited known cases of OSA without other significant co-morbidities, the association 
with NREM AHI in the RAI1 region was replicated in sex-combined analysis. This sample, 
however, was too small to test for sex-specific differences in associations. Although this 
observation needs to be cautiously interpreted, it is of interest that the strongest finding was for 
AHI in NREM sleep in the supine position. Men have a significantly higher proportion of apneas 
in NREM sleep than women, likely due to the occurrence of greater breathing instability in 
NREM sleep in men compared to women. Men also have more severe sleep apnea in the supine 
compared to non-supine position, attributed to the effects of positional-dependent airway 
collapsibility. In contrast, women show a REM-predominant pattern and less positional 
dependency (57). In other words, the lead SNP associated most strongly with a phenotype 
subtype most characteristic of “male” sleep apnea. The lack of significant association for this 
phenotype in our sex-combined discovery sample may reflect differences in the spectrum of 
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sleep apnea in the physiological study compared to the predominant community-based samples, 
where sleep apnea in women tends to be mild. 
 
Our study, while identifying novel genetic pathways that may influence OSA, was not designed 
to identify specific mechanisms. In particular, we were not able to assess to what extent the 
genetic associations with AHI could be explained by craniofacial features, differences in body fat 
distribution (particularly, neck circumference) or physiological traits due to lack of information 
on specific intermediate phenotypes in most of the study samples.  
 
In conclusion, we have identified from multi-ethnic meta-analyses several interesting biological 
candidates for sex-specific and sleep state-specific associations with AHI, the most widely used 
clinical measure for OSA. The approach underscores the value of sex-specific analyses in a trait 
such as OSA, for which there are significant differences in presentation and pathogenesis 
between men and women. It is widely recognized that the overall AHI likely reflects a 
heterogeneous set of phenotypes. The analysis of sleep state-specific (REM; Non-REM) findings 
allowed assessment of more specific OSA phenotypes (i.e., operating in the background of 
different levels of neuromuscular control) than the overall AHI. Further investigation of the RAI1 
regional association is particularly promising given its role in at least three congenital syndromes 
associated with sleep abnormalities and its influence on metabolic and physiological traits 
closely associated with OSA. However, future large-scale studies are warranted for replication 
and refinement of signals. These studies could lead to important insights into the underlying 
pathogenesis of the disorder, resulting in targeted treatments, as well as inform screening and risk 
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stratification. Additional insights into the genetic bases for OSA may be gleaned from further 
detailed phenotyping, including assessments of neuromuscular control of the airway.  
 
Acknowledgements 
The authors thank the staff and participants of the ARIC, CFS, FHS, HCHS/SOL, MESA, MrOS, 
Starr, KoGES_Ansan, CHS, CoLaus/HypnoLaus, SHIP-TREND, WASHS, and WSC studies for 
their important contributions. A full list of participating MESA investigators and institutions can 
be found at http://www.mesa-nhlbi.org. A full list of principal CHS investigators and institutions 
can be found at http://chs-nhlbi.org. SHIP is part of the Community Medicine Research net 
(CMR) of the University of Greifswald, Germany. The University of Greifswald is a member of 
the Caché Campus program of the InterSystems GmbH. The CMR encompasses several research 
projects which are sharing data of the population-based SHIP (http://ship.community-
medicine.de). This manuscript was not prepared in collaboration with investigators of ARIC, 
CHS or FHS, and does not necessarily reflect the opinions or views of ARIC, CHS, FHS or 
Boston University. The views expressed in this manuscript are those of the authors and do not 
necessarily represent the views of the National Heart, Lung, and Blood Institute; the National 
Institutes of Health; or the U.S. Department of Health and Human Services. 
 
Funding Support 
Han Chen was supported by National Institutes of Health (NIH) grants [R01-HL113338, P01-
CA134294, R35-CA197449]. Brian E. Cade is supported by NIH grants [T32-HL007901, R01-
HL113338]. Susan Redline is supported by NIH grants [R01-HL113338, R35-HL135818]. The 
15 
 
Sleep Reading Center of Brigham and Women's Hospital has been supported by NIH grants [5-
R01-HL046380-15 and 5-KL2-RR024990-05]. 
 
The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported 
by National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, 
HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, 
HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). 
 
The Framingham Heart Study is conducted and supported by NHLBI in collaboration with 
Boston University (Contract No. N01-HC-25195). Funding for SHARe Affymetrix genotyping 
was provided by NHLBI Contract N02-HL- 64278. SHARe Illumina genotyping was provided 
under an agreement between Illumina and Boston University. Funding support for the 
Framingham Sleep Heart Health Study was provided by NIH/NHLBI grant U01 HL 53941. 
 
The baseline examination of the Hispanic Community Health Study/Study of Latinos was carried 
out as a collaborative study supported by contracts from the NHLBI to the University of North 
Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of 
Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State 
University (N01-HC65237). The following Institutes/Centers/Offices contributed to the first 
phase of HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority 
Health and Health Disparities, National Institute on Deafness and Other Communication 
Disorders, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of 
Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Neurological 
16 
 
Disorders and Stroke (NINDS), and NIH Institution- Office of Dietary Supplements. The Genetic 
Analysis Center at the University of Washington was supported by NHLBI and NIDCR contracts 
(HHSN268201300005C AM03 and MOD03). Provision of genotyping services was supported in 
part by the National Center for Advancing Translational Sciences (NCATS) CTSI grant 
UL1TR000124 and NIDDK Diabetes Research Center (DRC) grant DK063491. 
 
The Multi-Ethnic Study of Atherosclerosis (MESA) is conducted and supported by the NHLBI in 
collaboration with MESA investigators. This research was supported by contracts 
HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-
HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 
and N01-HC-95169 from the NHLBI and by grants UL1-TR-000040 and UL1-TR-001079 from 
NCRR. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. 
Genotyping was performed at Affymetrix (Santa Clara, California, USA) and the Broad Institute 
of Harvard and MIT (Boston, Massachusetts, USA). Funding support for the Sleep 
Polysomnography dataset was provided by grant HL56984. Provision of genotyping services 
supported in part by NCATS CTSI grant UL1TR000124 and NIDDK DRC grant DK063491. 
 
The Osteoporotic Fractures in Men (MrOS) Study is supported by NIH funding. The following 
institutes provide support: the National Institute on Aging (NIA), the National Institute of 
Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NCATS, and NIH Roadmap for 
Medical Research under the following grant numbers: U01 AG027810, U01 AG042124, U01 
AG042139, U01 AG042140, U01 AG042143, U01 AG042145, U01 AG042168, U01 AR066160, 
and UL1 TR000128. The NHLBI provides funding for the MrOS Sleep ancillary study 
17 
 
"Outcomes of Sleep Disorders in Older Men" under the following grant numbers: R01 
HL071194, R01 HL070848, R01 HL070847, R01 HL070842, R01 HL070841, R01 HL070837, 
R01 HL070838, and R01 HL070839. The NIAMS provides funding for the MrOS ancillary 
study ‘Replication of candidate gene associations and bone strength phenotype in MrOS’ under 
the grant number R01 AR051124. The NIAMS provides funding for the MrOS ancillary study 
‘GWAS in MrOS and SOF’ under the grant number RC2 AR058973. 
 
The Starr County Health Studies is supported in part by grants R01 DK073541, 
U01 DK085501, R01 AI085014, and R01 HL102830 from the National Institutes of Health, and 
funds from The University of Texas Health Science Center at Houston. Graeme I. Bell supported 
in part by grant P30 DK020595 and a gift from the Kovler Family Foundation. 
 
KoGES_Ansan study was provided with biospecimens and data from the Korean Genome 
Analysis Project (4845-301), the Korean Genome and Epidemiology Study (2009-E71002-00, 
2010-E71001-00, 2011-E71004-00, 2012-E71005-00, 2013-E71005-00, 2014-E71003-00), and 
Korea Biobank Project (4851-307) that were supported by the Korea Centers for Disease Control 
& Prevention, Republic of Korea. 
 
This Cardiovascular Health Study research was supported by NHLBI contracts 
HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, 
N01HC85081, N01HC85082, N01HC85083, N01HC85086; and NHLBI grants U01HL080295, 
R01HL087652, R01HL105756, R01HL103612, R01HL120393, and R01HL130114 with 
additional contribution from NINDS. Genotyping among the African-American cohort was 
18 
 
supported in part by HL085251. Additional support was provided through R01AG023629 from 
NIA. The provision of genotyping data was supported in part by NCATS CTSI grant 
UL1TR000124, and NIDDK DRC grant DK063491 to the Southern California Diabetes 
Endocrinology Research Center.  
 
The HypnoLaus and CoLaus/HypnoLaus study was supported by research grants from 
GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, the Swiss National Science 
Foundation (grants 3200B0–105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468, and 
33CS30-148401), Leenaards Foundation, and Vaud Pulmonary League (Ligue Pulmonaire  
Vaudoise). 
 
The Study of Health in Pomerania is part of the Community Medicine Research net (CMR) of 
the University of Greifswald, Germany, which is funded by the Federal Ministry of Education 
and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), Competence Network Asthma/ 
COPD (FKZ 01GI0881-0888), the Ministry of Cultural Affairs as well as the Social Ministry of 
the Federal State of Mecklenburg-West Pomerania, and the network ‘Greifswald Approach to 
Individualized Medicine’ (GANI_MED) funded by the Federal Ministry of Education and 
Research (grant 03IS2061A). The polysomnography was additionally funded by the RLS e.V. 
(German Restless Legs Association).  
 
19 
 
Funding for the Western Australian Sleep Health Study was obtained from the Sir Charles 
Gairdner and Hollywood Private Hospital Research Foundations, the Western Australian Sleep 
Disorders Research Institute, and the Centre for Genetic Epidemiology and Biostatistics at the 
University of Western Australia. Funding for the GWAS genotyping obtained from the Ontario 
Institute for Cancer Research and a McLaughlin Centre Accelerator Grant from the University of 
Toronto. 
 
The Wisconsin Sleep Cohort (WSC) Study phenotype data collection was supported by US NIH 
grants R01HL62252 and 1UL1RR02501. GWAS typing of the WSC was conducted thanks to 
private donations and NIH-23724 to Dr. Emmanuel Mignot, Professor, Psychiatry and 
Behavioral Sciences, Stanford Center for Sleep Sciences and Medicine. 
 
References 
1. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with 
obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway 
pressure: An observational study. Lancet. 2005 Mar 19-25;365(9464):1046-53. 
2. Gottlieb DJ, Yenokyan G, Newman AB, O'Connor GT, Punjabi NM, Quan SF, et al. 
Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: 
The sleep heart health study. Circulation. 2010 Jul 27;122(4):352-60. 
3. Kendzerska T, Gershon AS, Hawker G, Tomlinson G, Leung RS. Obstructive sleep apnea and 
incident diabetes. A historical cohort study. Am J Respir Crit Care Med. 2014 Jul 15;190(2):218-
25. 
4. Alkhazna A, Bhat A, Ladesich J, Barthel B, Bohnam AJ. Severity of obstructive sleep apnea 
between black and white patients. Hosp Pract (1995). 2011 Oct;39(4):82-6. 
5. Redline S, Sotres-Alvarez D, Loredo J, Hall M, Patel SR, Ramos A, et al. Sleep-disordered 
breathing in hispanic/latino individuals of diverse backgrounds. the hispanic community health 
study/study of latinos. Am J Respir Crit Care Med. 2014 Feb 1;189(3):335-44. 
20 
 
6. Pensuksan WC, Chen X, Lohsoonthorn V, Lertmaharit S, Gelaye B, Williams MA. High risk 
for obstructive sleep apnea in relation to hypertension among southeast asian young adults: Role 
of obesity as an effect modifier. Am J Hypertens. 2014 Feb;27(2):229-36. 
7. Chen X, Wang R, Zee P, Lutsey PL, Javaheri S, Alcantara C, et al. Racial/ethnic differences in 
sleep disturbances: The multi-ethnic study of atherosclerosis (MESA). Sleep. 2015 Jun 
1;38(6):877-88. 
8. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered 
breathing among middle-aged adults. N Engl J Med. 1993 Apr 29;328(17):1230-5. 
9. Mohsenin V. Effects of gender on upper airway collapsibility and severity of obstructive sleep 
apnea. Sleep Med. 2003 Nov;4(6):523-9. 
10. Koo BB, Patel SR, Strohl K, Hoffstein V. Rapid eye movement-related sleep-disordered 
breathing: Influence of age and gender. Chest. 2008 Dec;134(6):1156-61. 
11. Wimms AJ, Ketheeswaran S, Armitstead JP. Obstructive sleep apnea in women: Specific 
issues and interventions. Sydney, Australia: ResMed Science Center; 2014. 
12. Hachul H, Frange C, Bezerra AG, Hirotsu C, Pires GN, Andersen ML, et al. The effect of 
menopause on objective sleep parameters: Data from an epidemiologic study in sao paulo, brazil. 
Maturitas. 2015 Feb;80(2):170-8. 
13. Redline S, Tishler PV, Tosteson TD, Williamson J, Kump K, Browner I, et al. The familial 
aggregation of obstructive sleep apnea. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):682-7. 
14. Patel SR, Larkin EK, Redline S. Shared genetic basis for obstructive sleep apnea and 
adiposity measures. Int J Obes (Lond). 2008 May;32(5):795-800. 
15. Larkin EK, Patel SR, Goodloe RJ, Li Y, Zhu X, Gray-McGuire C, et al. A candidate gene 
study of obstructive sleep apnea in european americans and african americans. Am J Respir Crit 
Care Med. 2010 Oct 1;182(7):947-53. 
16. Patel SR, Goodloe R, De G, Kowgier M, Weng J, Buxbaum SG, et al. Association of genetic 
loci with sleep apnea in european americans and african-americans: The candidate gene 
association resource (CARe). PLoS One. 2012;7(11):e48836. 
17. Yue W, Liu H, Zhang J, Zhang X, Wang X, Liu T, et al. Association study of serotonin 
transporter gene polymorphisms with obstructive sleep apnea syndrome in chinese han 
population. Sleep. 2008 Nov;31(11):1535-41. 
18. Cade BE, Chen H, Stilp AM, Gleason KJ, Sofer T, Ancoli-Israel S, et al. Genetic associations 
with obstructive sleep apnea traits in hispanic/latino americans. Am J Respir Crit Care Med. 
2016 Mar 15;194(7):886-97. 
21 
 
19. Randall JC, Winkler TW, Kutalik Z, Berndt SI, Jackson AU, Monda KL, et al. Sex-stratified 
genome-wide association studies including 270,000 individuals show sexual dimorphism in 
genetic loci for anthropometric traits. PLoS Genet. 2013 Jun;9(6):e1003500. 
20. Winkler TW, Justice AE, Graff M, Barata L, Feitosa MF, Chu S, et al. The influence of age 
and sex on genetic associations with adult body size and shape: A large-scale genome-wide 
interaction study. PLoS Genet. 2015 Oct 1;11(10):e1005378. 
21. Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Magi R, et al. New 
genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015 Feb 
12;518(7538):187-96. 
22. Link JC, Chen X, Prien C, Borja MS, Hammerson B, Oda MN, et al. Increased high-density 
lipoprotein cholesterol levels in mice with XX versus XY sex chromosomes. Arterioscler 
Thromb Vasc Biol. 2015 Aug;35(8):1778-86. 
23. Siddiqui F, Walters AS, Goldstein D, Lahey M, Desai H. Half of patients with obstructive 
sleep apnea have a higher NREM AHI than REM AHI. Sleep Med. 2006 Apr;7(3):281-5. 
24. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT, et al. Concept, 
design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale 
genomic association studies. PLoS One. 2008;3(10):e3583. 
25. Delaneau O, Marchini J, Zagury JF. A linear complexity phasing method for thousands of 
genomes. Nat Methods. 2011 Dec 4;9(2):179-81. 
26. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for 
the next generation of genome-wide association studies. PLoS Genet. 2009 Jun;5(6):e1000529. 
27. Zhou X, Stephens M. Genome-wide efficient mixed-model analysis for association studies. 
Nat Genet. 2012 Jun 17;44(7):821-4. 
28. Willer CJ, Li Y, Abecasis GR. METAL: Fast and efficient meta-analysis of genomewide 
association scans. Bioinformatics. 2010 Sep 1;26(17):2190-1. 
29. Elsea SH, Girirajan S. Smith-magenis syndrome. Eur J Hum Genet. 2008 Apr;16(4):412-21. 
30. Smith AC, Dykens E, Greenberg F. Sleep disturbance in smith-magenis syndrome (del 17 
p11.2). Am J Med Genet. 1998 Mar 28;81(2):186-91. 
31. Cakirer B, Hans MG, Graham G, Aylor J, Tishler PV, Redline S. The relationship between 
craniofacial morphology and obstructive sleep apnea in whites and in african-americans. Am J 
Respir Crit Care Med. 2001 Mar;163(4):947-50. 
22 
 
32. Williams SR, Zies D, Mullegama SV, Grotewiel MS, Elsea SH. Smith-magenis syndrome 
results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the 
maintenance of circadian rhythmicity. Am J Hum Genet. 2012 Jun 8;90(6):941-9. 
33. Gropman AL, Duncan WC, Smith AC. Neurologic and developmental features of the smith-
magenis syndrome (del 17p11.2). Pediatr Neurol. 2006 May;34(5):337-50. 
34. Brown A, Phelan MC, Patil S, Crawford E, Rogers RC, Schwartz C. Two patients with 
duplication of 17p11.2: The reciprocal of the smith-magenis syndrome deletion? Am J Med 
Genet. 1996 May 17;63(2):373-7. 
35. Potocki L, Chen KS, Park SS, Osterholm DE, Withers MA, Kimonis V, et al. Molecular 
mechanism for duplication 17p11.2- the homologous recombination reciprocal of the smith-
magenis microdeletion. Nat Genet. 2000 Jan;24(1):84-7. 
36. Potocki L, Bi W, Treadwell-Deering D, Carvalho CM, Eifert A, Friedman EM, et al. 
Characterization of potocki-lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-
sensitive critical interval that can convey an autism phenotype. Am J Hum Genet. 2007 
Apr;80(4):633-49. 
37. Lupski JR, Stankiewicz P. Genomic disorders: Molecular mechanisms for rearrangements 
and conveyed phenotypes. PLoS Genet. 2005 Dec;1(6):e49. 
38. Thaker VV, Esteves KM, Towne MC, Brownstein CA, James PM, Crowley L, et al. Whole 
exome sequencing identifies RAI1 mutation in a morbidly obese child diagnosed with ROHHAD 
syndrome. J Clin Endocrinol Metab. 2015 May;100(5):1723-30. 
39. Burns B, Schmidt K, Williams SR, Kim S, Girirajan S, Elsea SH. Rai1 haploinsufficiency 
causes reduced bdnf expression resulting in hyperphagia, obesity and altered fat distribution in 
mice and humans with no evidence of metabolic syndrome. Hum Mol Genet. 2010 Oct 
15;19(20):4026-42. 
40. Roadmap Epigenomics Consortium, Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, et 
al. Integrative analysis of 111 reference human epigenomes. Nature. 2015 Feb 
19;518(7539):317-30. 
41. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human 
genome. Nature. 2012 Sep 6;489(7414):57-74. 
42. Ward LD, Kellis M. HaploReg: A resource for exploring chromatin states, conservation, and 
regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012 
Jan;40(Database issue):D930-4. 
43. Vermunt MW, Reinink P, Korving J, de Bruijn E, Creyghton PM, Basak O, et al. Large-scale 
identification of coregulated enhancer networks in the adult human brain. Cell Rep. 2014 Oct 
23;9(2):767-79. 
23 
 
44. Westra HJ, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, et al. Systematic 
identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013 
Oct;45(10):1238-43. 
45. Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, Castagne R, et al. Genetics and 
beyond--the transcriptome of human monocytes and disease susceptibility. PLoS One. 2010 May 
18;5(5):e10693. 
46. Lappalainen T, Sammeth M, Friedlander MR, 't Hoen PA, Monlong J, Rivas MA, et al. 
Transcriptome and genome sequencing uncovers functional variation in humans. Nature. 2013 
Sep 26;501(7468):506-11. 
47. GTEx Consortium. Human genomics. the genotype-tissue expression (GTEx) pilot analysis: 
Multitissue gene regulation in humans. Science. 2015 May 8;348(6235):648-60. 
48. Li J, Nanayakkara A, Jun J, Savransky V, Polotsky VY. Effect of deficiency in SREBP 
cleavage-activating protein on lipid metabolism during intermittent hypoxia. Physiol Genomics. 
2007 Oct 22;31(2):273-80. 
49. Plantier L, Besnard V, Xu Y, Ikegami M, Wert SE, Hunt AN, et al. Activation of sterol-
response element-binding proteins (SREBP) in alveolar type II cells enhances lipogenesis 
causing pulmonary lipotoxicity. J Biol Chem. 2012 Mar 23;287(13):10099-114. 
50. Noga AA, Vance DE. A gender-specific role for phosphatidylethanolamine N-
methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very 
low density lipoproteins in mice. J Biol Chem. 2003 Jun 13;278(24):21851-9. 
51. Boone PM, Reiter RJ, Glaze DG, Tan DX, Lupski JR, Potocki L. Abnormal circadian rhythm 
of melatonin in smith-magenis syndrome patients with RAI1 point mutations. Am J Med Genet 
A. 2011 Aug;155A(8):2024-7. 
52. Cheng HY, Dziema H, Papp J, Mathur DP, Koletar M, Ralph MR, et al. The molecular 
gatekeeper Dexras1 sculpts the photic responsiveness of the mammalian circadian clock. J 
Neurosci. 2006 Dec 13;26(50):12984-95. 
53. CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, Willenborg C, Farrall M, 
Assimes TL, et al. Large-scale association analysis identifies new risk loci for coronary artery 
disease. Nat Genet. 2013 Jan;45(1):25-33. 
54. McCaffery PJ, Adams J, Maden M, Rosa-Molinar E. Too much of a good thing: Retinoic acid 
as an endogenous regulator of neural differentiation and exogenous teratogen. Eur J Neurosci. 
2003 Aug;18(3):457-72. 
55. Girirajan S, Patel N, Slager RE, Tokarz ME, Bucan M, Wiley JL, et al. How much is too 
much? phenotypic consequences of Rai1 overexpression in mice. Eur J Hum Genet. 2008 
Aug;16(8):941-54. 
24 
 
56. Redline S, Kapur VK, Sanders MH, Quan SF, Gottlieb DJ, Rapoport DM, et al. Effects of 
varying approaches for identifying respiratory disturbances on sleep apnea assessment. Am J 
Respir Crit Care Med. 2000 Feb;161(2 Pt 1):369-74. 
57. Lozo T, Komnenov D, Badr MS, Mateika JH. Sex differences in sleep disordered breathing 
in adults. Respir Physiol Neurobiol. 2017 Nov;245:65-75. 
  
 
25 
 
Figures 
Figure 1. Manhattan, quantile-quantile (Q-Q), and regional association plots of multi-ethnic 
meta-analysis results for AHI-N in men. A) The Manhattan plot shows minus log 10 p-values 
against genomic coordinates (NCBI build 37), and consecutive chromosomes were colored in 
black and grey alternately; B) The Q-Q plot shows observed minus log 10 p-values against 
expected values under no association; C) The regional association plot of multi-ethnic meta-
analysis results for AHI-N in men near the RAI1 gene on chromosome 17. 
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Figure 2. Sex differences in the distribution of BMI and BMI2 adjusted residuals for study 
subjects with different genotypes (AA, AG, and GG) of rs12936587. The phenotype is rank 
normalized sex-stratified residuals of AHI-N adjusting for age, age2. A) Men; B) Women. AfA: 
African-Americans; AsA: Asian-Americans; EuA: European-Americans; HsA: Hispanic/Latino-
Americans. 
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Tables 
 
Table 1. Sample description of study subjects in discovery cohorts. 
 
Ethnic Group Cohort N Age (years) Percent 
Female 
BMI (kg/m2) Apnea 
Hypopnea 
Index 
Percent 
OSA 
AHI-N AHI-R AHI-R/ 
AHI-N 
African-
Americans 
CFS* 731 37.84 (19.44) 56.2 31.63 (9.69) 5.85 (19.70) 31.7 2.47 
(12.19) 
9.23 
(30.87) 
2.89 
(8.70) 
 MESA 490 69.13 (9.10) 54.3 30.42 (5.71) 13.34 (21.16) 46.5 8.64 
(20.1) 
30.97 
(39.83) 
2.64 
(5.09) 
Asian-
Americans 
MESA 228 68.13 (9.19) 50.4 24.08 (3.19) 13.97 (23.90) 47.4 11.61 
(24.31) 
21.77 
(34.19) 
1.68 
(2.64) 
European-
Americans 
ARIC 1,463 62.43 (5.69) 51.5 28.83 (5.13) 8.70 (15.50) 32.5 5.75 
(13.78) 
16.46 
(27.68) 
2.58 
(4.69) 
 
CFS* 702 41.59 (19.45) 52.7 30.24 (8.66) 5.59 (18.99) 31.1 2.07 
(13.14) 
7.06 
(21.20) 
2.28 
(7.40) 
 FHS* 646 59.38 (8.97) 50.0 28.49 (5.01) 8.18 (14.51) 30.0 5.25 
(13.66) 
15.25 
(23.60) 
2.48 
(4.98) 
 MESA 707 68.52 (9.10) 53.6 27.99 (5.21) 12.62 (20.67) 44.0 9.61 
(20.45) 
22.31 
(30.65) 
1.80 
(2.97) 
 MrOS 2,209 76.68 (5.66) 0.0 27.22 (3.74) 12.73 (18.11) 43.7 10.93 
(19.58) 
18.30 
(24.17) 
1.53 
(2.42) 
Hispanic/Latino
-Americans  
HCHS/S
OL 
11,317 46.17 (13.79) 59.1 29.79 (6.00) 1.97 (6.20) 11.7 NA NA NA 
28 
 
Ethnic Group Cohort N Age (years) Percent 
Female 
BMI (kg/m2) Apnea 
Hypopnea 
Index 
Percent 
OSA 
AHI-N AHI-R AHI-R/ 
AHI-N 
 MESA 458 68.34 (9.20) 52.8 30.07 (5.52) 16.94 (23.05) 54.8 12.16 
(23.12) 
30.00 
(36.09) 
2.13 
(3.50) 
 Starr 782 52.34 (11.29) 71.9 32.15 (6.78) 10.35 (17.18) 37.1 NA NA NA 
Seven studies included 19,733 individuals with genotypes and phenotypes (1,221 African-Americans; 228 Asian-Americans; 5,727 
European-Americans; 12,557 Hispanic/Latino-Americans). NREM- and REM-specific data are only available in a sample of the CFS 
data and were not collected in HCHS/SOL and Starr County.  Mean (standard deviation) are listed for Age and BMI, and median 
(interquartile range) are listed for Apnea Hypopnea Index, AHI-N, AHI-R, and AHI-R/AHI-N. OSA: obstructive sleep apnea, defined as 
Apnea Hypopnea Index ≥ 15. AHI-N: NREM-specific Apnea Hypopnea Index. AHI-R: REM-specific Apnea Hypopnea Index. *: Family 
cohorts. 
 
 
 
Table 2. Significant and suggestive multi-ethnic meta-analysis results for AHI (total), AHI-NREM, and AHI-REM. 
 
     Sex-combined Women Men Sex diff 
Trait SNP Chr Locus Alleles N Effect P N Effect P N Effect P P 
AHI-T rs76321756 1  C/T 2,381 0.130 9.7×10
-5 1,289 -0.017 7.0×10-1 1,092 0.244 2.3×10-7 2.7×10-6 
AHI-T rs11897825 2 
AC011752.1; 
AC067959.1 
G/A 15,364 0.026 2.2×10-2 7.650 0.080 3.3×10-7 7,714 -0.014 3.6×10-1 2.8×10-3 
AHI-T rs999944 2  G/A 19,733 0.072 9.7×10
-7 10,113 0.063 2.0×10-3 9,620 0.077 2.6×10-4 5.5×10-3 
AHI-T rs35520189 2  C/A 19,733 0.052 6.1×10
-7 10,113 0.064 5.8×10-6 9,620 0.042 5.3×10-3 5.9×10-1 
AHI-T rs72149316:AATAA 2 SCN3A GATAA/ 1,679 0.428 6.0×10
-7 919 0.326 3.7×10-3 764 0.606 5.9×10-7 2.3×10-3 
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     Sex-combined Women Men Sex diff 
AATAA 
AHI-T rs34526934 2 
HOXD-
AS2;HOXD3;
HOXD4;MIR
10B 
A/T 19,505 0.060 1.1×10-6 9,998 0.024 1.7×10-1 9,507 0.087 3.6×10-7 1.8×10-3 
AHI-T rs62189527 2 HDAC4 C/T 12,665 0.174 4.6×10
-5 7,384 0.067 2.3×10-1 5,281 0.320 7.4×10-7 9.7×10-4 
AHI-T 
rs35001935:CGTG
TGT 
3 
C3orf67; 
RP11-
147N17.1 
CGTGT/ 
CGTGTG
T 
1,679 0.251 7.7×10-7 919 0.091 1.9×10-1 760 0.339 1.3×10-6 3.3×10-4 
AHI-T chr3:166153534:D 3  A/AAC 2.461 0.249 3.4×10
-5 1,481 0.376 6.1×10-7 980 0.157 9.4×10-2 3.2×10-1 
AHI-T rs34188544 4  G/A 2,135 0.522 3.6×10
-7 1,264 0.333 1.4×10-2 871 0.728 2.1×10-6 8.2×10-3 
AHI-T rs73352871 5  C/A 12,996 0.082 2.4×10
-3 7,610 -0.025 4.8×10-1 5,386 0.203 5.9×10-7 2.2×10-6 
AHI-T rs79987021 7  T/C 12,265 0.256 6.2×10
-7 7,199 0.186 5.4×10-3 5,066 0.316 7.7×10-5 1.5×10-2 
AHI-T rs117004340 8 DLC1 T/A 19,504 0.079 2.2×10
-5 9,997 -0.001 9.7×10-1 9,507 0.136 1.8×10-7 9.2×10-4 
AHI-T rs3736021 8 ENTPD4 T/G 19,732 0.065 7.2×10
-7 10,112 0.057 1.1×10-3 9,620 0.071 3.4×10-4 1.1×10-1 
AHI-T rs35857674 8 SNTG1 A/G 19,732 0.024 2.2×10
-2 10,112 0.070 7.9×10-7 9,620 -0.016 2.8×10-1 5.2×10-3 
AHI-T rs117169866 10  G/A 18,512 0.150 5.6×10
-7 9,436 0.116 7.0×10-3 9,396 0.158 1.1×10-4 6.7×10-2 
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     Sex-combined Women Men Sex diff 
AHI-T rs1387259 12 
RP11-
370I10.2; 
ZNF641 
A/G 19,733 0.052 2.3×10-6 10,113 0.031 4.1×10-2 9,620 0.078 3.7×10-7 2.3×10-2 
AHI-T rs9600832 13 NBEA C/T 19,733 0.064 1.2×10
-5 10,113 0.012 5.4×10-1 9,620 0.104 5.6×10-7 7.8×10-5 
AHI-T rs75900232 13  G/A 16,337 0.159 2.1×10
-4 8,942 -0.037 5.2×10-1 8,199 0.307 6.5×10-7 4.9×10-5 
AHI-T rs115432071 16 C16orf62 T/A 12,996 0.197 8.5×10
-6 7,610 0.055 3.4×10-1 5,386 0.346 3.0×10-7 1.6×10-4 
AHI-T rs4787347 16 HS3ST4 G/A 19,733 0.029 3.3×10
-3 10,113 0.067 7.2×10-7 9,620 0.002 8.8×10-1 1.9×10-1 
AHI-T rs112190082 17 STX8 G/T 13,905 0.099 1.0×10
-3 8,188 0.200 3.6×10-7 5,717 0.013 7.7×10-1 3.4×10-2 
AHI-T rs113724004 17  T/C 19,505 0.069 5.9×10
-5 9,998 0.020 4.0×10-1 9,507 0.123 8.0×10-7 3.9×10-4 
AHI-T rs142002225 20  T/C 19,733 0.055 2.8×10
-4 10,113 0.108 3.2×10-7 9,620 0.022 3.1×10-1 3.4×10-1 
AHI-N rs146579140 2  C/T 6,737 0.206 8.8×10
-8 2,412 0.092 1.6×10-1 4,212 0.237 5.2×10-7 1.3×10-2 
AHI-N rs10474877 5 ANKRD33B T/C 6,737 0.039 1.1×10
-1 2,412 0.203 2.1×10-7 4,212 -0.015 6.2×10-1 3.7×10-2 
AHI-N rs73686127 7  A/T 1,300 0.508 2.6×10
-7 719 0.509 4.7×10-5 367 0.464 4.6×10-3 2.2×10-1 
AHI-N rs10968431 9 LINGO2 G/A 1,300 0.239 5.3×10
-4 719 -0.030 7.5×10-1 581 0.474 9.7×10-7 1.3×10-5 
AHI-N rs79697311 11  C/A 6,029 0.215 5.2×10
-3 1,295 0.719 6.9×10-7 3,885 0.176 6.9×10-2 4.2×10-1 
AHI-N rs34174435 11 OR5AN1 GA/G 5,304 0.101 6.4×10
-7 1,673 0.105 4.4×10-3 3,631 0.086 3.3×10-4 1.1×10-1 
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     Sex-combined Women Men Sex diff 
AHI-N rs75482679 11 CNTN5 T/C 6,737 0.128 1.0×10
-5 2,412 -0.019 6.9×10-1 4,325 0.176 8.7×10-7 1.3×10-4 
AHI-N rs72986876 11 PDGFD A/T 6,511 0.223 7.8×10
-7 2,299 0.194 1.3×10-2 4,212 0.217 7.9×10-5 4.4×10-1 
AHI-N rs116696666 16  A/T 1,300 0.290 1.6×10
-3 719 0.608 5.9×10-7 581 0.136 3.1×10-1 2.5×10-1 
AHI-N rs12936587 17 RAI1 G/A 6,737 0.083 6.9×10
-7 2,412 -0.008 7.7×10-1 4,325 0.116 1.7×10-8 2.6×10-5 
AHI-R chr1:74135031 1 
RP4-
788P17.1 
A/T 1,546 0.310 9.8×10-7 858 0.208 1.0×10-2 688 0.403 5.2×10-5 1.2×10-1 
AHI-R rs72956768 4 TMEM154 G/T 1,290 0.254 6.4×10
-4 714 0.020 8.3×10-1 576 0.563 5.2×10-7 1.5×10-4 
AHI-R rs35077018 7 
HUS1; 
PKD1L1 
G/GCTA
GTGCGT
GCATGA
ACTAGT
TGGTCT
GCAAGT
ACAAGA
TGTATA
AATATA
CAGGG
GAAAA
AACATC 
1,290 0.198 5.5×10-4 714 0.357 8.2×10-7 576 0.049 5.9×10-1 3.4×10-2 
AHI-R rs9297743 8 
RP11-
89K10.1 
G/A 6,700 0.127 5.5×10-4 2,400 -0.037 5.1×10-1 4,300 0.241 9.2×10-7 2.6×10-3 
AHI-R rs79697311 11  C/A 5,998 0.173 1.8×10
-2 1,289 0.692 4.4×10-7 3,867 0.068 4.7×10-1 4.6×10-2 
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     Sex-combined Women Men Sex diff 
AHI-R rs201360344 12 C12orf55 G/GA 924 0.478 5.5×10
-7 498 0.516 3.2×10-5 426 0.329 3.1×10-2 4.1×10-1 
AHI-R rs41408454 15  G/A 1,290 0.287 1.1×10
-3 714 0.523 8.8×10-7 576 0.019 8.9×10-1 1.2×10-2 
SNPs with significant (p < 5.0 x 10-8) and suggestive (p < 1.0 x 10-6) p-values. SNPs that were present in only one ethnic group were 
excluded. AHI-T: AHI (total). AHI-N: AHI during NREM. AHI-R: AHI during REM. Alleles: effect allele / non-effect allele. 
 
